This research report aims to deeply explore the relevant issues of the project and provide valuable information to investors. This article does not constitute any investment advice, please invest rationally.
Worth noting:
Bio Protocol to be listed on Binance Launchpool
Maximum token supply: 3,320,000,000 BIO (supply can be increased through network governance)
Launchpool Total: 99,600,000 BIO (3% of the total Genesis token supply)
BNB pool: total reward 84,660,000 BIO (85%)
FDUSD pool: total reward 14,940,000 BIO (15%)
Time: Starting from 08:00 on December 24 (GMT+8), the BIO event will last for 10 days
Listing time: Binance will list Bio Protocol (BIO) at 18:00 (ET) on January 3, 2025.
Portal: https://accounts.binance.com/register?ref=764109512
Project Introduction
BIO Protocol is DeSci’s financial layer, designed to accelerate the flow of capital and talent into on-chain science. bioDAO can raise funds using BIO Protocol’s auction contracts and direct funds to research initiatives, IP assets, and other biotech organizations.
Project Investment
2024-11-08Completed strategic financing, invested by Binance Lbas, the amount was not disclosed; BIO Protocol announced on August 20 that it had completed the first round of Genesis auction financing of US$6.22 million, exceeding the original target of approximately US$5 million. Before the seed round, the project had raised US$900,000 and was valued at approximately US$35 million. In the seed round, the project raised US$1.4 million and was valued at approximately US$69 million. Public financing: The public fundraising process is the public BIO Genesis auction. It consists of 3 rounds: In Genesis Round 1, the project raised US$6.2 million and was valued at approximately US$85 million. In Genesis Round 2, the project raised US$18.2 million and was valued at approximately US$142 million. In Genesis Round 2.5, the project raised US$3.5 million and was valued at approximately US$219 million.
Project Advantages
Innovative financing models
Decentralized funding: Through blockchain technology, anyone can invest in promising biotechnology projects, breaking the high threshold of traditional scientific research funding.
Capital efficiency: Pooling patient data, capital, labor and other resources to significantly reduce the cost of biotechnology innovation.
Improve research efficiency
Fast funding process: BIO uses on-chain voting and funding allocation mechanisms to enable scientists to obtain funding faster and reduce the time wasted on applying for funding.
Diversified portfolio: By bundling biotech projects together, investors can reduce the risk of a single project failing.
Promoting global collaboration
Global pool of talent and capital: BIO agreements allow scientists, researchers, and investors around the world to contribute their talents and resources to specific research areas, regardless of geographic boundaries.
Shared intellectual property: Through tokenization mechanisms, intellectual property can be jointly owned and managed, breaking down traditional IP and licensing barriers and promoting collaboration and innovation.
Strengthening community engagement
Patient community driven: Patients can not only invest, but also directly influence research outcomes by contributing data or voting on research directions, improving incentive alignment between scientists and patients.
Liquid Market: Provides early exit mechanisms for traditionally illiquid biotech assets, making investments more flexible.
Technology drives innovation
On-chain liquidity protocol: BIO Protocol draws on the DeFi mechanism to support the continuous development of the project through AMM and deep liquidity pools.
Decentralized Governance: Through the BIO token, the community is able to collectively decide which projects receive support, while giving BioDAO the impetus for continued growth.
Ecosystem Advantages
Launchpad Support: Through BIO Launchpad, we will provide BioDAO with legal framework, governance support, brand building, and Web3 tools to accelerate its growth.
Liquidity Engine: Provides funding support and token liquidity through the protocol’s own liquidity pool to enhance the project’s attractiveness.
Token Allocation
Binance Launchpool accounts for 3.00% of total supply
Team 21.20% of total supply
Advisors 4.70% of total supply
Private equity investors account for 13.60% of the total supply
Molecule AG investors (pro rata) 7.60% of total supply
Pre-Seed and Seed investors account for 6.00% of the total supply
Molecule AG 5.00% of total supply
Community Auction / Public Investors 20.00% of total supply
Community airdrops account for 6.00% of the total supply
Community Airdrop - 1 1.00% of total supply
Community Airdrop - 2 3.00% of total supply
Community Airdrop - 3 2.00% of total supply
Molecule Community Fund 5.00% of total supply
Ecosystem Incentives (bio/acc rewards) 4.00% of total supply
Ecosystem Incentives (Treasury) 15.00% of total supply
Liquidity and Marketing 2.50% of total supply
Project Evaluation
BIO Protocol is an important innovative project in the DeSci field. With decentralized financing, tokenized intellectual property rights and global scientific research collaboration, it solves the pain points of the lengthy traditional scientific funding process, the difficulty of commercializing early results and the uneven distribution of resources. The project's Launchpad and liquidity protocols provide more efficient and transparent support for scientific research, while allowing the patient community to directly participate in research decisions, enhancing the actual value and social impact of research. However, when facing challenges such as market competition, regulatory compliance and technical governance, the project needs to continue to optimize its ecosystem and core technology to ensure that it maintains its leading position in the rapidly developing DeSci field.
$BNB $BTC